|
Objective: To study Kin liver particles the treatment of chronic hepatitis B Qiyinliangxu stasis and Shenling Yigan particles clinical efficacy for the treatment of chronic hepatitis B liver and gallbladder damp heat and stagnation and spleen deficiency Certificate of contrast, a preliminary study of Chinese medicine treatment of chronic hepatitis B different syndromes, to improve the characteristics of the same symptoms and advantages. Methods: All patients are from August 2002 to August 2006 Affiliated Hospital of Hubei University of Chinese Medicine Center for Liver Diseases outpatient and inpatient qualified participants meet the diagnostic criteria of chronic hepatitis B, a total of 44 cases of which have been confirmed as gas 22 cases of patients with yin deficiency and blood stasis, Ⅰ treatment group; diagnosed 22 cases of liver depression and spleen and gallbladder damp heat and chief for II treatment group. TCM treatment of proprietary Chinese medicine granules. Observed before and after treatment the main symptoms and signs (hypochondriac pain, fatigue, anorexia, bloating, loose stools, boredom), liver function, B ultrasonic changes in circumstances, to evaluate the effect of Chinese medicine in patients with chronic hepatitis B improve clinical symptoms JiangMei the . Results: 1 before treatment, the clinical symptoms (hypochondriac pain, fatigue, anorexia, bloating, loose stools, bored,) was not statistically significant (P gt; 0.05), two sets of symptoms clinically comparable. Which hypochondriac pain, fatigue, anorexia, comparing the bloating the two groups before and after treatment can significantly improve (P lt; 0.01) between the two groups before and after treatment can significantly improve (P lt; 0.01). Will improve the pond with boredom before and after treatment (P lt; 0.05) after treatment, loose stools March Ⅰ treatment group improved (P lt; 0.05) than the treatment group II II treatment group boredom January improvement than Ⅰ treatment group (P lt; 0.05). Before and after treatment in two groups of ALT in the dynamic observation of the first 1, 2, 3 months, were extended with the treatment decreased (P lt; 0.01), the two treatment groups had lower ALT efficacy; Ⅰ treatment group ALT in the treatment of after 1, 2 and 3 months, respectively, compared with the treatment group II were statistically significant (P lt; 0.05), two proprietary Chinese medicines particles can improve liver damage. Before and after treatment in two groups AST dynamic observation of the first 1, 2, 3 months, were extended with the treatment decreased (P lt; 0.01), the two treatment groups were lower AST efficacy; Ⅰ treatment group AST in the treatment of after 1, 2 and 3 months, respectively, compared with the treatment group II were statistically significant (P lt; 0.05), two proprietary Chinese medicines particles can improve liver damage. Dynamic observation of the first 1,2,3 months AKP two groups before and after treatment, all with the treatment extended gradually decreased, I treatment group (P lt; 0.01), Ⅱ treatment group (P lt; 0.05); treatment 1,2 months, the two groups had no statistical significance (P gt; 0.05); treatment for the first three months, the two groups were statistically significant (P lt; 0.05) illustrate two proprietary Chinese medicines particles have reduce the AKP long-term effects. 5 After treatment, A / G compared with before treatment, were not statistically significant (P gt; 0.05); 1, 2 and 3 months after treatment, the two groups, there was no statistical significance (P gt; 0.05 ). 6, 2, 3 months before and after treatment in two groups TBIL dynamic observation (P lt; 0.05); treatment of 1,2 months decreased with treatment extended, the two groups was not statistically significant (P gt; 0.05); 3 months of treatment, the two groups were statistically significant (P lt; 0.05), two proprietary Chinese medicines particles all have lower the TBIL forward role. 7, 2, 3 months before and after treatment in two groups DBIL dynamic observation, extend over treatment decreased (P lt; 0.05); treatment of 1,2 months, the two groups was not statistically significant (P gt ; 0.05); 3 months of treatment, the two groups were statistically significant (P lt; 0.05), two proprietary Chinese medicines particles has to reduce DBIL forward role. Improve the situation before and after the 8 two groups of B-treatment was not statistically significant (P gt; 0.05). 9 the two groups JiangMei comprehensive efficacy comparison Ⅰ treatment group markedly effective rate of 9.09%, the efficiency of 31.82%, the total effective rate of 40.91%, Ⅱ treatment group markedly effective rate of 13.64%, 36.36% efficiency, the total effective rate of 50%, two groups statistically significant (P gt; 0.05). The Conclusion: Kin liver particles and Shenling Yigan particles has to improve the efficacy of chronic hepatitis B syndrome, in improving the hypochondriac pain, fatigue, anorexia, bloating symptoms is particularly significant effect; particles and parameters of liver function, liver health Ling Liver and particles has a significant effect on reducing ALT and AST, reduce therapeutic TBIL and DBIL, had no significant effect in the improve A / G; no significant effect in improving B-; JiangMei aspects, before and after treatment curative.
|